Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Abac raises €16M series A

February 16, 2018 7:12 PM UTC

Abac Therapeutics S.A. (Barcelona, Spain) raised €16 million ($19.6 million) on Feb. 15 in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital Risc and Debiopharm Innovation Fund participated, as did existing investor Ferrer.

Abac uses its PasNas platform to discover antibiotics targeting Gram-negative bacteria. The company expects the financing will allow it to begin clinical studies of its lead program, which targets multi-drug resistant Acinetobacter baumannii...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Abac Therapeutics S.A.